about
The IKK complex contributes to the induction of autophagyInhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathwayCell proliferation depends on mitochondrial Ca2+ uptake: inhibition by salicylateBiomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrateMultipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos.An automated fluorescence videomicroscopy assay for the detection of mitotic catastropheCharacterization of novel MPS1 inhibitors with preclinical anticancer activityResveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention.Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity SetCoffee induces autophagy in vivoVitamin B6 improves the immunogenicity of cisplatin-induced cell death.Classification of current anticancer immunotherapiesIllicit survival of cancer cells during polyploidization and depolyploidization.Single-Cell Phenotypic Characterization of Human Pituitary GHomas and Non-Functioning Adenomas Based on Hormone Content and Calcium Responses to Hypothalamic Releasing HormonesSelective killing of p53-deficient cancer cells by SP600125.Independent transcriptional reprogramming and apoptosis induction by cisplatin.Chemosensitization strategies for the treatment of lung cancer.Trial watch: Dendritic cell-based interventions for cancer therapyTrial watch: Prognostic and predictive value of the immune infiltrate in cancerMorphometric analysis of immunoselection against hyperploid cancer cellsVitamin B6 metabolism influences the intracellular accumulation of cisplatin.Immunosurveillance against tetraploidization-induced colon tumorigenesis.Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagy.Functions of BCL-X L at the Interface between Cell Death and MetabolismThe oncolytic peptide LTX-315 triggers immunogenic cell death.Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer.Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer.Trial watch: DNA vaccines for cancer therapy.The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer.Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer.Positive impact of autophagy in human breast cancer cells on local immunosurveillance.Immunogenic cell death modalities and their impact on cancer treatment.Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling.Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8.Viral subversion of immunogenic cell death.Analgesic, anti-inflammatory and anticancer activities of extra virgin olive oil.IKK connects autophagy to major stress pathways.Viral strategies for the evasion of immunogenic cell death.Surface-exposed calreticulin in the interaction between dying cells and phagocytes.Molecular mechanisms of cisplatin resistance.
P50
Q24329117-6FD69598-BA65-4D85-AD68-A4D24E0AD47DQ27302281-8A71647A-C711-4CD4-90CA-EAD7A87F1DA1Q28193861-F759827D-7802-4D4E-B1FC-F298B9396577Q30276247-FE978C75-25B3-44E5-B3CA-5ECDBD8AA0FBQ30494172-E0FF58E3-B1A9-4ABB-A34D-372A6EE0DE56Q30498067-598B2717-E6CE-4E00-AD29-CF14FAA261D7Q30549643-6BFF9A56-1E73-4836-A0AB-D1283CD4F875Q30573152-E9F3EA21-B6B8-46EB-A35B-F1B84EC50AC5Q33776379-5E7C16C8-CCDD-47A4-96FB-206550419C09Q33953155-E1DC1AA1-3A13-40DB-8D72-24942C4E93EEQ34933129-E85B5B7A-8E03-4D49-8440-F4B8091678BAQ35149637-0D438BCE-DEF1-4730-B8CB-007B5AD5DF2AQ35227425-81FDC80A-7133-4963-BFFA-344D1CFA3F5BQ35701772-B3406D57-16BC-4CB5-91FF-BAD6B005F92DQ36238666-5B0EDD37-FB36-4461-8C97-C8DD1B22C14AQ36304190-8139DC65-B664-4F41-B1D7-C7DA0782A0F6Q36352608-5B4AC599-1FB1-4F3A-A2A7-3768FAB0FC46Q36388529-103BF2FC-ED46-4B75-90D2-967928E115CCQ36456483-8B0551B4-B0FB-41FE-B529-C13AE0B669BCQ36562331-9C713D6C-72DD-41D8-84E1-0E1C62C7DBC0Q36654372-4C64BE7E-4CF2-42CA-997D-B906129D66DBQ36654387-9C10B8D4-6BCE-4BC8-B9B0-6DDCF91C5A04Q36662373-52CE94DF-853A-4009-A7D6-418D40E468E9Q36702748-D18FE59F-863A-48CA-A57E-4F245FD8B30DQ36774984-91DA0C1A-5985-4B46-981B-D7DA4A173E1DQ36777278-C97B4D28-1A7E-4F50-B415-EAC8ADB4BE97Q36798051-CC8E85CE-D2F2-4152-9D02-8B35C650A72BQ36845824-675A2C2D-B4AF-4A8C-BBD7-D537872E0EB1Q36862687-11867693-20C3-43F7-82C9-908C71E61F5CQ37079087-6AF6C5D4-F5D9-4D2F-A502-B5C65DF38F68Q37079091-86D2F650-4D04-4E22-B3DF-F6FD5C81EB01Q37368966-8D09D0A5-BDA9-41E4-9990-795B7A93146FQ37379390-192F2526-0EB7-48DF-8E68-BD68887FEC16Q37379408-8FBF65C4-EEAA-4078-AB76-5B497B2A69A0Q37394561-41B2E911-DEED-412C-8D84-19262F350B20Q37448501-0E3C0ED8-068A-47CB-8697-D3DB8632454CQ37683307-2DBA5F61-1F73-413D-97B8-C9C78EDC141DQ37740184-96B05E5E-7B07-431B-833B-35D35B0485C7Q37801397-C0EC69A0-27C6-418A-8A65-00F73A65479BQ37926477-3F543628-5F17-4368-B312-867908A242CD
P50
description
bióloga molecular española
@ast
hulumtuese
@sq
researcher
@en
spanische Molekularbiologin
@de
taighdeoir
@ga
հետազոտող
@hy
name
Laura Senovilla
@ast
Laura Senovilla
@ca
Laura Senovilla
@en
Laura Senovilla
@es
Laura Senovilla
@fr
Laura Senovilla
@ga
Laura Senovilla
@sl
Laura Senovilla
@sq
type
label
Laura Senovilla
@ast
Laura Senovilla
@ca
Laura Senovilla
@en
Laura Senovilla
@es
Laura Senovilla
@fr
Laura Senovilla
@ga
Laura Senovilla
@sl
Laura Senovilla
@sq
altLabel
Laura Senovilla González
@en
prefLabel
Laura Senovilla
@ast
Laura Senovilla
@ca
Laura Senovilla
@en
Laura Senovilla
@es
Laura Senovilla
@fr
Laura Senovilla
@ga
Laura Senovilla
@sl
Laura Senovilla
@sq
P19
P2038
Laura_Senovilla
P21
P27
P31
P496
0000-0001-6887-2436
P569
1978-01-01T00:00:00Z
P6634
laura-senovilla-344b8492